The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Katkin Keith since 2019.
This trader's CIK number is 1314596.
At the time of last reporting, Katkin Keith was the Director of Emergent Biosolutions Inc.. (stock ticker symbol EBS).
Also see all insider trading activities at Emergent Biosolutions Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | UROV | 0 | $0 | 0 | $0 | 180,000 | $694,800 |
| 2019 | UROV | 0 | $0 | 120,000 | $1,533,600 | 120,000 | $463,200 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | SNDX | 10,000 | $91,120 | 0 | $0 | 0 | $0 |
| 2022 | SNDX | 0 | $0 | 29,899 | $774,413 | 29,899 | $251,301 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | EBS | 0 | $0 | 7,844 | $49,417 | 0 | $0 |
1. Urovant Sciences Ltd. (UROV)
2. Syndax Pharmaceuticals Inc (SNDX)
3. Emergent Biosolutions Inc. (EBS)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-02-19 | UROV | Option Ex | 180,000 | 3.86 | 694,800 |
| 2019-12-09 | UROV | Option Ex | 120,000 | 3.86 | 463,200 |
| 2019-12-09 | UROV | Sale | 120,000 | 12.78 | 1,533,600 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-19 | SNDX | Buy | 10,000 | 9.11 | 91,120 |
| 2022-10-06 | SNDX | Option Ex | 29,899 | 8.40 | 251,301 |
| 2022-10-06 | SNDX | Sale | 29,899 | 25.90 | 774,413 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-23 | EBS | Sale | 7,844 | 6.30 | 49,417 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Katkin Keith (Director of Emergent Biosolutions Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.